MIC-1 COMPOUNDS AND USE THEREOF

The invention relates to MIC-1 compounds. More specifically it relates to compounds comprising a MIC-1 polypeptide and an N-terminal amino acid extension, wherein said extension consists of 3 to 36 amino acid residues and where the compound has a calculated pI lower than 6.5. The compounds of the in...

Full description

Saved in:
Bibliographic Details
Main Authors Iversen, Lars Fogh, Hansen, Kristian Tage, Guan, Hongtao, Thoegersen, Henning, Wang, Yi, Zhang, Xujia, Noergaard, Per, Joergensen, Sebastian Beck, Sass-Oerum, Kristian, Gao, Xiang
Format Patent
LanguageEnglish
Published 01.07.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to MIC-1 compounds. More specifically it relates to compounds comprising a MIC-1 polypeptide and an N-terminal amino acid extension, wherein said extension consists of 3 to 36 amino acid residues and where the compound has a calculated pI lower than 6.5. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.
Bibliography:Application Number: US202117194908